ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
98 301,13
0,55%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Ocean Biomedical Inc (OCEA) Cours

Ocean Biomedical Inc

Ocean Biomedical Inc (OCEA)

NASDAQ
0,6641
0,0751
(12,75%)
Fermé 21 Décembre 10:00PM
Retardé de 15 minutes
0,6131
-0,051
(-7,68%)
Après les heures de négociation: 1:46AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,6131
Prix Achat
0,613
Prix Vente
0,6829
Volume échangé
9 118 215
0,4603 Fourchette du Jour 0,7174
0,52 Plage de 52 semaines 7,79
Cap du marché
21,347M
Clôture Veille
0,589
Ouverture
0,5546
Dernière Transaction
2000
@
0.6131
(formt)
Dernière heure de transaction
Volume financier
US$ 5 194 815
VWAP
0,569718
Volume moyen (3 m)
51 489
Actions en circulation
34 818 628
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-3,03
Bénéfice par action (BPA)
-3,29
Chiffre d'affairess
-
Bénéfice net
-114,47M

À propos de Ocean Biomedical Inc

Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Aesther Healthcare Acquisition Corp is a newly-organized blank check company. It is formed for the purpose effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.aestherhealthcarespac.com
Siège social
Dover, Delaware, USA
Fondé
-
Ocean Biomedical Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker OCEA. Le dernier cours de clôture d'Ocean Biomedical était de US$0,59. Au cours de la dernière année, les actions de Ocean Biomedical ont été négociées dans une fourchette de prix de US$ 0,52 à US$ 7,79.

Ocean Biomedical compte actuellement 34 818 628 actions en circulation. La capitalisation boursière d'Ocean Biomedical est de US$20,51 million. Ocean Biomedical a un ratio cours/bénéfice (ratio PE) de -3.03.

OCEA Dernières nouvelles

Plus de nouvelles

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market...

22 Novembre 2024
GlobeNewswire Inc.

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The...

22 Octobre 2024
GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Publication of New Data Deepening Understanding of Novel Cancer Immunotherapy Treatment Approach Targeting CHI3L1 and its Ability to Inhibit Anti-tumor and Related Tissue Remodeling Responses

Ocean Biomedical’s Anti-CHI3L1 patent coverage includes multiple methods of use for targeting a broad range of Cancers that include Lung Cancer, Glioblastoma, Prostate Cancer, Melanoma, and Breast...

01 Octobre 2024
GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms

Providence, RI, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that its Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been issued a key U.S. patent...

27 Août 2024
GlobeNewswire Inc.

Form 8-K - Current report

23 Août 2024
Edgar (US Regulatory)

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on August 19, 2024, it received a notice from The Nasdaq Stock Market LLC...

23 Août 2024
GlobeNewswire Inc.

Form 8-K - Current report

23 Juillet 2024
Edgar (US Regulatory)

Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positive Immunogenicity Results from Their Lead Checkpoint Modifier-Containing Immunotherapy, VRON-0200, for HBV Functional Cure, at EASL 2024

Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the development of compelling discoveries from top research...

05 Juin 2024
GlobeNewswire Inc.

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PROVIDENCE, Rhode Island, May 30, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on May 22, 2024, it received a notice from The Nasdaq Stock Market...

30 Mai 2024
GlobeNewswire Inc.

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease

Providence, RI, May 16, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ:OCEA) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his...

16 Mai 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.0659-9.705449189990.6790.69990.5681513940.61963743CS
4-0.0869-12.41428571430.70.760.5681433700.67395809CS
12-0.3119-33.71891891890.9251.160.5681514890.8489448CS
26-0.7969-56.51773049651.411.690.5681677511.04594263CS
520.02313.915254237290.597.790.5217980532.95796845CS
156-9.3469-93.844377519.9626.59860.5215810204.7377768CS
260-9.3469-93.844377519.9626.59860.5215810204.7377768CS

OCEA - Frequently Asked Questions (FAQ)

What is the current Ocean Biomedical share price?
The current share price of Ocean Biomedical is US$ 0,6131
How many Ocean Biomedical shares are in issue?
Ocean Biomedical has 34 818 628 shares in issue
What is the market cap of Ocean Biomedical?
The market capitalisation of Ocean Biomedical is USD 20,51M
What is the 1 year trading range for Ocean Biomedical share price?
Ocean Biomedical has traded in the range of US$ 0,52 to US$ 7,79 during the past year
What is the PE ratio of Ocean Biomedical?
The price to earnings ratio of Ocean Biomedical is -3,03
What is the reporting currency for Ocean Biomedical?
Ocean Biomedical reports financial results in USD
What is the latest annual profit for Ocean Biomedical?
The latest annual profit of Ocean Biomedical is USD -114,47M
What is the registered address of Ocean Biomedical?
The registered address for Ocean Biomedical is 8 THE GREEN, STE A, KENT, DOVER, DELAWARE, 19901
What is the Ocean Biomedical website address?
The website address for Ocean Biomedical is www.aestherhealthcarespac.com
Which industry sector does Ocean Biomedical operate in?
Ocean Biomedical operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
OCEA
Ocean Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés